Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of BioAtla Inc (NASDAQ: BCAB) was $0.31 for the day, down -12.63% from the previous closing price of $0.36. In other words, the price has decreased by -$12.63 from its previous closing price. On the day, 3.21 million shares were traded. BCAB stock price reached its highest trading level at $0.3865 during the session, while it also had its lowest trading level at $0.3105.
Ratios:
Our analysis of BCAB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.54.
On September 15, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.JMP Securities initiated its Mkt Outperform rating on September 15, 2022, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 18501870 and an Enterprise Value of 16362870.
Stock Price History:
The Beta on a monthly basis for BCAB is 1.08, which has changed by -0.27999997 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, BCAB has reached a high of $1.43, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -57.40%, while the 200-Day Moving Average is calculated to be -42.19%.
Shares Statistics:
BCAB traded an average of 1.71M shares per day over the past three months and 2608900 shares per day over the past ten days. A total of 58.79M shares are outstanding, with a floating share count of 44.91M. Insiders hold about 23.92% of the company’s shares, while institutions hold 15.65% stake in the company. Shares short for BCAB as of 1767139200 were 4316860 with a Short Ratio of 2.53, compared to 1764288000 on 6190599. Therefore, it implies a Short% of Shares Outstanding of 4316860 and a Short% of Float of 8.32.
Earnings Estimates
The dynamic stock of BioAtla Inc (BCAB) is currently attracting attention from 1.0 analysts actively involved in rating its market status. Analysts are recommending an EPS of between -$1.08 and -$1.08 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.92, with 1.0 analysts recommending between -$0.92 and -$0.92.
